메뉴 건너뛰기




Volumn 47, Issue SUPPL., 2000, Pages

The mechanism of arginine- and insulin-induced GH release in humans

Author keywords

Arginine; GH; GHRH Antagonist; ITT; Normal Adults

Indexed keywords

ARGININE; INSULIN;

EID: 0034106926     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.47.supplmarch_s23     Document Type: Article
Times cited : (6)

References (8)
  • 1
    • 0029933620 scopus 로고    scopus 로고
    • The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects
    • Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K (1996) The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects. J Clinical Endocrinol Metab 81: 1952-1955.
    • (1996) J Clinical Endocrinol Metab , vol.81 , pp. 1952-1955
    • Hanew, K.1    Tanaka, A.2    Utsumi, A.3    Sugawara, A.4    Abe, K.5
  • 3
    • 0030039638 scopus 로고    scopus 로고
    • Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli
    • Jaffe CA, Friberg RD, Barkan AL (1996) Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli. J Clin Invest 97: 934-940.
    • (1996) J Clin Invest , vol.97 , pp. 934-940
    • Jaffe, C.A.1    Friberg, R.D.2    Barkan, A.L.3
  • 5
    • 0031896952 scopus 로고    scopus 로고
    • Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine (PD), sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome
    • Hanew K, Tanaka A, Utsumi A (1998) Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine (PD), sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome. J Endocrinol Invest 21: 72-77.
    • (1998) J Endocrinol Invest , vol.21 , pp. 72-77
    • Hanew, K.1    Tanaka, A.2    Utsumi, A.3
  • 6
    • 0031741589 scopus 로고    scopus 로고
    • Secretory mechanisms of growth hormone (GH)-releasing peptide, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly
    • Hanew K, Utsumi A, Tanaka A, Ikeda H, Yokogoshi Y (1998) Secretory mechanisms of growth hormone (GH)-releasing peptide, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly. J Clin Endocrinol Metab 83: 3578-3583.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 3578-3583
    • Hanew, K.1    Utsumi, A.2    Tanaka, A.3    Ikeda, H.4    Yokogoshi, Y.5
  • 8
    • 0028968462 scopus 로고
    • Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level
    • Popovic V, Damjanovic S, Micic D, Djurovic M, Diguez C, Casanueva FF (1995) Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80: 3180-3184.
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 3180-3184
    • Popovic, V.1    Damjanovic, S.2    Micic, D.3    Djurovic, M.4    Diguez, C.5    Casanueva, F.F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.